Ciaramella Giuseppe's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Dec 14, 2022
- Accession no.
- 0000899243-22-038538
- Filed
- Dec 14, 2022
- Trade date
- Dec 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.18M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000899243-22-039103 (Dec 20, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaramella GiuseppeCIK 0001786322 | Officer (President & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | MOption exerciseAcquired | +18,211 | $0.67 | +$12,201.37 | 133,825 | Direct | |
| Dec 12, 2022 | Common Stock | MOption exerciseAcquired | +8,652 | $4.22 | +$36,511.44 | 142,477 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −31,699 | $42.30F3 | −$1,340,867.7 | 110,778 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −13,933 | $43.15F4 | −$601,208.95 | 96,845 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −5,383 | $43.87F5 | −$236,152.21 | 91,462 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | MOption exerciseDisposed | −18,211 | $0.00 | $0 | 189,491 | Direct | |
| Dec 12, 2022 | Common Stock | MOption exerciseDisposed | −8,652 | $0.00 | $0 | 4,326 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.74 to $42.71, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.76 to $43.75, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.76 to $44.06, inclusive.
Referenced by the price of 1 transaction in Table I.